Trans-activated interferon-α2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle

Pierre Cordelier, Sandra A. Calarota, David S. Strayer

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Several lines of evidence suggest a potential major role for interferon (IFN) in controlling HIV-1 replication. However, this inhibition is moderate and is reversible upon IFN removal. To achieve prolonged high concentrations of IFN at the site of infection, we devised an SV40-based vector, SV[HIVLTR]IFN, to direct the synthesis of human IFN-α2, by employing a virus-trans-activated human IFN-α2 gene to be transcribed in response to HIV-1 infection. Expression of IFN-α2 was confirmed by Northern and Western blotting, in SV[HIVLTR]IFN-transduced, HIV-1-challenged human lymphocyte lines and primary human lymphocytes. SV[HIVLTR]IFN-transduced cells showed no evidence of HIV-1-related cytophatic effects when challenged with high doses of HIV-1 NL4-3. As measured by supernatant HIV-1 p24 antigen concentration, IFN-α2-expressing cell lines and peripheral blood lymphocytes (PBL) were protected from high-dose challenges of HIV-1. rSV40-delivered IFN-α2 inhibited gp120 protein synthesis and expression of HIV-1 mRNAs. Finally, Southern analysis revealed that levels of proviral DNA were markedly reduced in SV[HIVLTR]IFN-transduced cells compared to control cultures. IFN-α2 expression driven by HIVLTR delivered by an rSV40 vector thus strongly inhibits HIV-1 replication, probably by blocking a preintegration step in HIV-1 infection. Targeted expression of IFN-α2 delivered by SV40 can thus repress HIV-1 replication, and may be a useful approach to HIV-1 treatment.

Original languageEnglish
Pages (from-to)817-828
Number of pages12
JournalJournal of Hematotherapy and Stem Cell Research
Volume11
Issue number5
DOIs
Publication statusPublished - Oct 2002

Fingerprint

Interferons
HIV-1
T-Lymphocytes
Lymphocytes
HIV Infections
HIV Core Protein p24
Northern Blotting
Western Blotting
Viruses

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Trans-activated interferon-α2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle. / Cordelier, Pierre; Calarota, Sandra A.; Strayer, David S.

In: Journal of Hematotherapy and Stem Cell Research, Vol. 11, No. 5, 10.2002, p. 817-828.

Research output: Contribution to journalArticle

@article{affe4e28cde849f3af7297aec01a9730,
title = "Trans-activated interferon-α2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle",
abstract = "Several lines of evidence suggest a potential major role for interferon (IFN) in controlling HIV-1 replication. However, this inhibition is moderate and is reversible upon IFN removal. To achieve prolonged high concentrations of IFN at the site of infection, we devised an SV40-based vector, SV[HIVLTR]IFN, to direct the synthesis of human IFN-α2, by employing a virus-trans-activated human IFN-α2 gene to be transcribed in response to HIV-1 infection. Expression of IFN-α2 was confirmed by Northern and Western blotting, in SV[HIVLTR]IFN-transduced, HIV-1-challenged human lymphocyte lines and primary human lymphocytes. SV[HIVLTR]IFN-transduced cells showed no evidence of HIV-1-related cytophatic effects when challenged with high doses of HIV-1 NL4-3. As measured by supernatant HIV-1 p24 antigen concentration, IFN-α2-expressing cell lines and peripheral blood lymphocytes (PBL) were protected from high-dose challenges of HIV-1. rSV40-delivered IFN-α2 inhibited gp120 protein synthesis and expression of HIV-1 mRNAs. Finally, Southern analysis revealed that levels of proviral DNA were markedly reduced in SV[HIVLTR]IFN-transduced cells compared to control cultures. IFN-α2 expression driven by HIVLTR delivered by an rSV40 vector thus strongly inhibits HIV-1 replication, probably by blocking a preintegration step in HIV-1 infection. Targeted expression of IFN-α2 delivered by SV40 can thus repress HIV-1 replication, and may be a useful approach to HIV-1 treatment.",
author = "Pierre Cordelier and Calarota, {Sandra A.} and Strayer, {David S.}",
year = "2002",
month = "10",
doi = "10.1089/152581602760404621",
language = "English",
volume = "11",
pages = "817--828",
journal = "Journal of Hematotherapy and Stem Cell Research",
issn = "1525-8165",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Trans-activated interferon-α2 delivered to T cells by SV40 inhibits early stages in the HIV-1 replicative cycle

AU - Cordelier, Pierre

AU - Calarota, Sandra A.

AU - Strayer, David S.

PY - 2002/10

Y1 - 2002/10

N2 - Several lines of evidence suggest a potential major role for interferon (IFN) in controlling HIV-1 replication. However, this inhibition is moderate and is reversible upon IFN removal. To achieve prolonged high concentrations of IFN at the site of infection, we devised an SV40-based vector, SV[HIVLTR]IFN, to direct the synthesis of human IFN-α2, by employing a virus-trans-activated human IFN-α2 gene to be transcribed in response to HIV-1 infection. Expression of IFN-α2 was confirmed by Northern and Western blotting, in SV[HIVLTR]IFN-transduced, HIV-1-challenged human lymphocyte lines and primary human lymphocytes. SV[HIVLTR]IFN-transduced cells showed no evidence of HIV-1-related cytophatic effects when challenged with high doses of HIV-1 NL4-3. As measured by supernatant HIV-1 p24 antigen concentration, IFN-α2-expressing cell lines and peripheral blood lymphocytes (PBL) were protected from high-dose challenges of HIV-1. rSV40-delivered IFN-α2 inhibited gp120 protein synthesis and expression of HIV-1 mRNAs. Finally, Southern analysis revealed that levels of proviral DNA were markedly reduced in SV[HIVLTR]IFN-transduced cells compared to control cultures. IFN-α2 expression driven by HIVLTR delivered by an rSV40 vector thus strongly inhibits HIV-1 replication, probably by blocking a preintegration step in HIV-1 infection. Targeted expression of IFN-α2 delivered by SV40 can thus repress HIV-1 replication, and may be a useful approach to HIV-1 treatment.

AB - Several lines of evidence suggest a potential major role for interferon (IFN) in controlling HIV-1 replication. However, this inhibition is moderate and is reversible upon IFN removal. To achieve prolonged high concentrations of IFN at the site of infection, we devised an SV40-based vector, SV[HIVLTR]IFN, to direct the synthesis of human IFN-α2, by employing a virus-trans-activated human IFN-α2 gene to be transcribed in response to HIV-1 infection. Expression of IFN-α2 was confirmed by Northern and Western blotting, in SV[HIVLTR]IFN-transduced, HIV-1-challenged human lymphocyte lines and primary human lymphocytes. SV[HIVLTR]IFN-transduced cells showed no evidence of HIV-1-related cytophatic effects when challenged with high doses of HIV-1 NL4-3. As measured by supernatant HIV-1 p24 antigen concentration, IFN-α2-expressing cell lines and peripheral blood lymphocytes (PBL) were protected from high-dose challenges of HIV-1. rSV40-delivered IFN-α2 inhibited gp120 protein synthesis and expression of HIV-1 mRNAs. Finally, Southern analysis revealed that levels of proviral DNA were markedly reduced in SV[HIVLTR]IFN-transduced cells compared to control cultures. IFN-α2 expression driven by HIVLTR delivered by an rSV40 vector thus strongly inhibits HIV-1 replication, probably by blocking a preintegration step in HIV-1 infection. Targeted expression of IFN-α2 delivered by SV40 can thus repress HIV-1 replication, and may be a useful approach to HIV-1 treatment.

UR - http://www.scopus.com/inward/record.url?scp=0036800797&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036800797&partnerID=8YFLogxK

U2 - 10.1089/152581602760404621

DO - 10.1089/152581602760404621

M3 - Article

VL - 11

SP - 817

EP - 828

JO - Journal of Hematotherapy and Stem Cell Research

JF - Journal of Hematotherapy and Stem Cell Research

SN - 1525-8165

IS - 5

ER -